Literature DB >> 31996108

Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken.

Michael Lynge Pedersen1.   

Abstract

Diabetes used to be a rare condition among Inuit in Greenland. However, research in recent decades has shown a high prevalence of undiagnosed diabetes. Addressing diabetes in the geographically dispersed population of Greenland presents a challenge to the health care system. In 2008, a new model of diabetes care was introduced in Greenland that included continual monitoring, analysis, and adjustment of initiatives taken. The overall aim of this review was to review the feasibility of the monitoring of an ongoing national diabetes care programme. After ten years of observation it was clear that monitoring of such a programme based on information in electronic medical records in Greenland was feasible. It was found that the majority of the population in Greenland was in contact with the health care system. Increased diagnostic activity resulted in an increased prevalence of diagnosed diabetes. The quality of diabetes care in Greenland and the testing effectiveness of gestational diabetes were improved. Microvascular complications were frequently observed among Greenlandic diabetic patients, except for retinopathy that was as an exception. In summary, this model may improve diabetes care and potentially care for other chronic conditions in Greenland, and may also be helpful in other remote settings where chronic disease care is difficult.Abbreviations: AD: Anno Domini; ADA: American Diabetes Association; BC: Before Christ; BMI: Body Mass Index; BP: Blood Pressure; CWB: Capillary Whole Blood; EMR: Electronic Medical Record; EASD: European Association for Study of Diabetes; GA: Gestational Age; GDM: Gestational Diabetes Mellitus; FIGO: The International Federation of Gynaecology and Obstetrics; HbA1c: Glycosylated haemoglobin; IDF: International Diabetes Federation; LDL: Low density lipoprotein; NDQIA: National Diabetes Quality Improvement Alliancel; NICE: National Institute for Health and Care Excellence; OECD: Organisation for Economic Co-operation and Development; OGTT: Oral Glucose Tolerance Test; QIH: Queen Ingrid Hospital; RCT: Randomised Controlled Tria;l T1D: Type 1 Diabetes; T2D: Type 2 Diabetes; UACR: Urine Albumin Creatinine Ratio; WHO: World Health Organisation.

Entities:  

Keywords:  Diabetes; Indigenous; gestational diabetes; microvascular complication; prevalence; quality of care; remote area

Mesh:

Year:  2019        PMID: 31996108      PMCID: PMC7034430          DOI: 10.1080/22423982.2019.1709257

Source DB:  PubMed          Journal:  Int J Circumpolar Health        ISSN: 1239-9736            Impact factor:   1.228


  186 in total

1.  Improvement of diabetes care in a small but geographically widely spread population in Greenland. Effects of a national diabetes care programme.

Authors:  M L Pedersen; J L Jacobsen
Journal:  Diabet Med       Date:  2011-11       Impact factor: 4.359

2.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

3.  Diabetes in Greenland and its relationship with urbanization.

Authors:  M E Jørgensen; K Borch-Johnsen; D R Witte; P Bjerregaard
Journal:  Diabet Med       Date:  2012-06       Impact factor: 4.359

4.  End-stage renal disease due to diabetes among southwestern American Indians, 1990-2001.

Authors:  Nilka Ríos Burrows; Andrew S Narva; Linda S Geiss; Michael M Engelgau; Kelly J Acton
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

5.  Prevalence of diabetes mellitus in pregnancy among Yup'ik Eskimos, 1987-1988.

Authors:  N J Murphy; L R Bulkow; C D Schraer; A P Lanier
Journal:  Diabetes Care       Date:  1993-01       Impact factor: 19.112

6.  A multicenter, randomized trial of treatment for mild gestational diabetes.

Authors:  Mark B Landon; Catherine Y Spong; Elizabeth Thom; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Kristine Y Lain; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland B Anderson
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

Review 7.  Insulin for the treatment of women with gestational diabetes.

Authors:  Julie Brown; Luke Grzeskowiak; Kathryn Williamson; Michelle R Downie; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-11-05

8.  Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Authors:  Alexander Thompson; Emanuele Di Angelantonio; Pei Gao; Nadeem Sarwar; Sreenivasa Rao Kondapally Seshasai; Stephen Kaptoge; Peter H Whincup; Kenneth J Mukamal; Richard F Gillum; Ingar Holme; Inger Njølstad; Astrid Fletcher; Peter Nilsson; Sarah Lewington; Rory Collins; Vilmundur Gudnason; Simon G Thompson; Naveed Sattar; Elizabeth Selvin; Frank B Hu; John Danesh
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

9.  Validation of bedside methods in evaluation of diabetic peripheral neuropathy.

Authors:  P Jayaprakash; Anil Bhansali; Shobhit Bhansali; Pinaki Dutta; R Anantharaman; G Shanmugasundar; M Ravikiran
Journal:  Indian J Med Res       Date:  2011-06       Impact factor: 2.375

10.  Uncovering the genetic history of the present-day Greenlandic population.

Authors:  Ida Moltke; Matteo Fumagalli; Thorfinn S Korneliussen; Jacob E Crawford; Peter Bjerregaard; Marit E Jørgensen; Niels Grarup; Hans Christian Gulløv; Allan Linneberg; Oluf Pedersen; Torben Hansen; Rasmus Nielsen; Anders Albrechtsen
Journal:  Am J Hum Genet       Date:  2014-12-31       Impact factor: 11.025

View more
  6 in total

1.  An LDLR missense variant poses high risk of familial hypercholesterolemia in 30% of Greenlanders and offers potential of early cardiovascular disease intervention.

Authors:  Emil Jørsboe; Mette K Andersen; Line Skotte; Frederik F Stæger; Nils J Færgeman; Kristian Hanghøj; Cindy G Santander; Ninna K Senftleber; Lars J Diaz; Maria Overvad; Ryan K Waples; Frank Geller; Peter Bjerregaard; Mads Melbye; Christina V L Larsen; Bjarke Feenstra; Marit E Jørgensen; Niels Grarup; Ida Moltke; Anders Albrechtsen; Torben Hansen
Journal:  HGG Adv       Date:  2022-06-09

2.  Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study.

Authors:  Abdullah Ghassan Muhammad; Frederik Orm Hansen; Rasmus Hvidbjerg Gantzel; Karsten Fleischer Rex; Gerda Elisabeth Villadsen; Henning Grønbæk; Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.941

3.  Eye care delivery models to improve access to eye care for Indigenous peoples in high-income countries: a scoping review.

Authors:  Helen Burn; Lisa Hamm; Joanna Black; Anthea Burnett; Matire Harwood; Matthew J Burton; Jennifer R Evans; Jacqueline Ramke
Journal:  BMJ Glob Health       Date:  2021-03

4.  Prevalence of patients using antihypertensive medication in Greenland, and an assessment of the importance of diagnosis for the associated quality of care - a cross-sectional study.

Authors:  Maja Hykkelbjerg Nielsen; Marie Balslev Backe; Michael Lynge Pedersen
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.941

5.  Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case-Control Study.

Authors:  Sidsel Dan Hull; Marianne Welzel Andersen; Jessica Bengtsson; Nils Skovgaard; Marie Balslev Backe; Michael Lynge Pedersen
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

6.  Low prevalence of retinopathy among Greenland Inuit.

Authors:  Trine Louise Jul Larsen; Marit Eika Jørgensen; Michael Lynge Pedersen; Henrik Lund-Andersen; Marianne Valerius; Ellen Juul; Stine Byberg
Journal:  Int J Circumpolar Health       Date:  2021-12       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.